Breaking News Instant updates and real-time market news.

GILD

Gilead

$80.38

2.01 (2.56%)

14:17
02/07/18
02/07
14:17
02/07/18
14:17

Gilead's Biktarvy HIV combo receives FDA approval

Biktarvy is a three-drug combination of bictegravir, a human immunodeficiency virus type 1 integrase strand transfer inhibitor, and emtricitabine and tenofovir alafenamide, both HIV-1 nucleoside analog reverse transcriptase inhibitors, and was approved by the FDA as a complete regimen for the treatment of HIV-1 infection in adults who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen for at least 3 months with no history of treatment failure and no known substitutions associated with resistance to the individual components of Biktarvy, according to a post to the agency's website. Reference Link

  • 12

    Feb

GILD Gilead
$80.38

2.01 (2.56%)

02/07/18
SBSH
02/07/18
NO CHANGE
Target $105
SBSH
Buy
Gilead should be bought ahead of pipeline catalysts, says Citi
Citi analyst Robyn Karnauskas raised her price target for Gilead Sciences to $105 from $103 following last night's Q4 results. The analyst recommends buying the stock ahead of pipeline catalysts and keeps a Buy rating on the name. The base business seems to be stabilizing while gene therapy could be a potential growth area, Karnauskas tells investors in a post-earnings research note.
01/31/18
JEFF
01/31/18
NO CHANGE
JEFF
Jefferies sees neutral impact on Biotech from State of the Union
Jefferies analyst Michael Yee sees a net neutral impact on Biotech stocks from President Trump's State of the Union speech last night. During the speech, Trump made comments about making lower drug prices a "priority" for the year, Yee tells investors in a research not titled "Drug Pricing Comments Not New or Surprising - But a Reminder of Rhetoric." The President, however, also commented on broader access to novel clinical trial drugs, Yee points out. After a "strong biotech rally" in January, the analyst assumes the sector, "at some point," will have some relative near-term pullback either on uncertainty about Trump commentary or some consolidation. Some of the analyst's Buy-rated names include AbbVie (ABBV), Amgen (AMGN), Eli Lilly (LLY) and Gilead Sciences (GILD).
01/30/18
01/30/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. CVS Health (CVS) upgraded to Strong Buy from Buy at Needham by analyst Kevin Caliendo, who contended that the stock remains underowned and, unlike its peers, yet to rally beyond the expectations of benefits from the tax changes. The analyst says the company's multiple has remained constant despite the expansion in the rest of the pharma services industry, forecasting EPS growth of 8%-10% beyond the modeled $8 per share in 2019. 2. JetBlue (JBLU) upgraded to Overweight from Neutral at JPMorgan by analyst Jamie Bakier who said the company's costs are "gradually coming under control" and its balance sheet is "sound." The analyst also upgraded United Continental (UAL) to Overweight from Underweight, saying the shares are the "cheapest in the sector and among the most washed out, having declined the most from recent highs." 3. Gilead (GILD) upgraded to Buy from Neutral at Citi by analyst Robyn Karnauskas, who said that tax reform could lower the company's tax rate to 22% in 2018 versus prior estimates of 28%. The analyst also raised her nonalcoholic steatohepatitis and JAK-1 probability of success estimates to 50% with both Phase 3 trials expected in the next 12 months. Further, Karnauskas expects Gilead's hepatitis C virus business to stabilize by mid-2018. 4. Intel (INTC) upgraded to Buy from Neutral at Citi by analyst Christopher Danely, who said overly conservative guidance and poor sentiment from years of underperformance should drive estimates and the stock higher in the near term. He believes management's "new habit" of conservative guidance is good for the stock. 5. Albemarle (ALB) upgraded to Buy from Neutral at UBS by analyst John Roberts, who said the stock is down 23% from the November high despite no change to the outlook for lithium. The analyst attributes the pullback to larger scale lithium expansion announcements and raising concerns of potential oversupply. He believes the market is pricing in 10% annual realized price declines for Albemarle over the next few years. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/30/18
SBSH
01/30/18
UPGRADE
Target $103
SBSH
Buy
Citi upgrades Gilead to Buy with $103 target following tax reform
Citi analyst Robyn Karnauskas upgraded Gilead Sciences to Buy from Neutral and raised her price target for the shares to $103 from $81. The drugmaker closed yesterday up $3.34 to $88.80. Tax reform could lower the company's tax rate to 22% in 2018 versus prior estimates of 28%, Karnauskas tells investors in a research note. The analyst also raised her nonalcoholic steatohepatitis and JAK-1 probability of success estimates to 50% with both Phase 3 trials expected in the next 12 months. Further, Karnauskas expects Gilead's hepatitis C virus business to stabilize by mid-2018.

TODAY'S FREE FLY STORIES

02:45
02/23/18
02/23
02:45
02/23/18
02:45
General news
FX Update: The dollar has traded moderately higher »

FX Update: The dollar…

02:05
02/23/18
02/23
02:05
02/23/18
02:05
General news
Asian Market Wrap: »

Asian Market Wrap: Asian…

PEG

PSEG

$49.18

0.65 (1.34%)

, COG

Cabot Oil & Gas

$23.88

0.63 (2.71%)

20:25
02/22/18
02/22
20:25
02/22/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PEG

PSEG

$49.18

0.65 (1.34%)

COG

Cabot Oil & Gas

$23.88

0.63 (2.71%)

HUN

Huntsman

$33.32

-0.27 (-0.80%)

CNK

Cinemark

$39.72

0.1 (0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 26

    Feb

  • 28

    Feb

  • 05

    Mar

  • 23

    May

DOVA

Dova Pharmaceuticals

$32.78

-0.08 (-0.24%)

19:57
02/22/18
02/22
19:57
02/22/18
19:57
Syndicate
Dova Pharmaceuticals 2.5M share Secondary priced at $32.00 »

JPMorgan, Jefferies and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 23

    Feb

SPY

SPDR S&P 500 ETF Trust

$270.40

0.35 (0.13%)

, SPX

S&P 500

19:25
02/22/18
02/22
19:25
02/22/18
19:25
Periodicals
Breaking Periodicals news story on SPDR S&P 500 ETF Trust, S&P 500 »

Treasury Sec.: Trump…

SPY

SPDR S&P 500 ETF Trust

$270.40

0.35 (0.13%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMAB

OMA Airports

$41.47

0.33 (0.80%)

19:10
02/22/18
02/22
19:10
02/22/18
19:10
Hot Stocks
OMA Airports reports Q4 passenger traffic up 1.8% »

Total terminal passenger…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIV

Aimco

$38.28

0.28 (0.74%)

19:05
02/22/18
02/22
19:05
02/22/18
19:05
Hot Stocks
Aimco acquires Bent Tree apartment community for $160M »

Apartment Investment and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KDMN

Kadmon

$3.60

-0.16 (-4.26%)

18:49
02/22/18
02/22
18:49
02/22/18
18:49
Hot Stocks
Kadmon updates 'positive' results from Phase 2 study of KD025 in cGVHD »

Kadmon announced updated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASR

Asur

$182.83

1.49 (0.82%)

18:47
02/22/18
02/22
18:47
02/22/18
18:47
Hot Stocks
Asur reports Q4 passenger traffic down 4% »

ASUR's total…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USB

U.S. Bancorp

$54.27

-0.83 (-1.51%)

18:45
02/22/18
02/22
18:45
02/22/18
18:45
Periodicals
Judge criticizes U.S. Bancorp deal to sidestep prosecution, Bloomberg reports »

U.S. District Judge Lewis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 30

    May

KZIA

Kazia Therapeutics

$4.99

0.43 (9.43%)

18:36
02/22/18
02/22
18:36
02/22/18
18:36
Hot Stocks
Kazia granted orphan status for glioblastoma treatment »

The FDA granted Kazia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OBE

Obsidian Energy

$0.98

0.0183 (1.91%)

18:29
02/22/18
02/22
18:29
02/22/18
18:29
Hot Stocks
Obsidian Energy reports 126% reserve replacement of 2017 production »

Obsidian Energy said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OBE

Obsidian Energy

$0.98

0.0183 (1.91%)

18:27
02/22/18
02/22
18:27
02/22/18
18:27
Hot Stocks
Obsidian Energy names Jay Thornton chairman of the board »

Obsidian Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSRM

SSR Mining

$8.33

0.06 (0.73%)

18:27
02/22/18
02/22
18:27
02/22/18
18:27
Earnings
SSR Mining reports Q4 adjusted EPS 2c, consensus 7c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

SSRM

SSR Mining

$8.33

0.06 (0.73%)

18:21
02/22/18
02/22
18:21
02/22/18
18:21
Hot Stocks
SSR Mining sees 2018 gold production 340K gold equivalent ounces »

SSR Mining expect to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

IVC

Invacare

$17.97

-0.28 (-1.53%)

18:20
02/22/18
02/22
18:20
02/22/18
18:20
Hot Stocks
Invacare names Kathleen Leneghan as CFO, effective immediately »

Invacare announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

SHCAY

Sharp

$8.21

-0.025 (-0.30%)

18:18
02/22/18
02/22
18:18
02/22/18
18:18
Periodicals
Sharp drops legal action against Hisense over TV brands, Nikkei reports »

Sharp has dropped legal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$40.91

0.35 (0.86%)

18:17
02/22/18
02/22
18:17
02/22/18
18:17
Periodicals
GM seeks South Korean aid to bolster local unit, Nikkei Asian Review reports »

General Motors is seeking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJI

South Jersey Industries

$26.34

0.23 (0.88%)

18:14
02/22/18
02/22
18:14
02/22/18
18:14
Earnings
Breaking Earnings news story on South Jersey Industries »

South Jersey Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

TRTN

Triton International

$28.16

-0.4 (-1.40%)

18:13
02/22/18
02/22
18:13
02/22/18
18:13
Earnings
Triton International reports Q4 adjusted EPS 85c, consensus 80c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

SJI

South Jersey Industries

$26.34

0.23 (0.88%)

18:13
02/22/18
02/22
18:13
02/22/18
18:13
Earnings
Breaking Earnings news story on South Jersey Industries »

South Jersey Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

PAA

Plains All American

$20.97

-0.43 (-2.01%)

18:09
02/22/18
02/22
18:09
02/22/18
18:09
Hot Stocks
Plains All American's Cactus II pipeline fully committed »

Plains All American…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 07

    Mar

STX

Seagate

$51.36

-0.08 (-0.16%)

18:03
02/22/18
02/22
18:03
02/22/18
18:03
Initiation
Seagate initiated at Stifel »

Seagate resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

WDC

Western Digital

$85.53

-0.14 (-0.16%)

18:01
02/22/18
02/22
18:01
02/22/18
18:01
Initiation
Western Digital initiated at Stifel »

Western Digital resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$21.39

0.22 (1.04%)

17:56
02/22/18
02/22
17:56
02/22/18
17:56
Hot Stocks
Breaking Hot Stocks news story on HP Inc. »

HP Inc. sees higher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 24

    Apr

  • 30

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.